1-5 of 5
F. Stephen Hodi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma

Elizabeth I. Buchbinder, Justine V. Cohen, Giuseppe Tarantino, Christine G. Lian, David Liu, Rizwan Haq, F. Stephen Hodi, Donald P. Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J. Sullivan
Journal: Cancer Research Communications
Cancer Research Communications (2024) 4 (5): 1321–1327.
https://doi.org/10.1158/2767-9764.CRC-24-0036
Published: 21 May 2024
View article titled, A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma
Open the PDF for A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma in another window
Includes: Supplementary data
Journal Articles

Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study

Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
Journal: Cancer Research Communications
Cancer Research Communications (2024) 4 (3): 785.
https://doi.org/10.1158/2767-9764.CRC-24-0133
Published: 13 March 2024
View article titled, Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study
Open the PDF for Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study in another window
Journal Articles

Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study

Pamela Munster, Nicholas Iannotti, Daniel C. Cho, John M. Kirkwood, Liza C. Villaruz, Geoffrey T. Gibney, F. Stephen Hodi, Niharika B. Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven O'Day
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (12): 2572–2584.
https://doi.org/10.1158/2767-9764.CRC-22-0461
Published: 19 December 2023
View article titled, Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study
Open the PDF for Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study in another window
Includes: Supplementary data
Journal Articles

Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia

Glenn J. Hanna, Alessandro Villa, Nikhil Mistry, Yonghui Jia, Charles T. Quinn, Madison M. Turner, Kristen D. Felt, Kathleen Pfaff, Robert I. Haddad, Ravindra Uppaluri, Scott J. Rodig, Sook-Bin Woo, Ann Marie Egloff, F. Stephen Hodi
Journal: Cancer Research Communications
Cancer Research Communications (2022) 2 (5): 390.
https://doi.org/10.1158/2767-9764.CRC-22-0193
Published: 19 May 2022
View article titled, Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia
Open the PDF for Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia in another window
Journal Articles

Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia

Glenn J. Hanna, Alessandro Villa, Nikhil Mistry, Yonghui Jia, Charles T. Quinn, Madison M. Turner, Kristen D. Felt, Kathleen Pfaff, Robert I. Haddad, Ravindra Uppaluri, Scott J. Rodig, Sook-Bin Woo, Ann Marie Egloff, F. Stephen Hodi
Journal: Cancer Research Communications
Cancer Research Communications (2021) 1 (1): 30–40.
https://doi.org/10.1158/2767-9764.CRC-21-0060
Published: 13 October 2021
View article titled, Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia
Open the PDF for Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia in another window
Includes: Supplementary data